Literature DB >> 18085377

Neutralization of CXCL10 accelerates liver regeneration in carbon tetrachloride-induced acute liver injury.

Hiroyuki Yoneyama1, Yoshiro Kai, Jun Koyama, Kenji Suzuki, Hiroshi Kawachi, Shosaku Narumi, Takafumi Ichida.   

Abstract

Remodeling of hepatic tissue structure following injury requires the coordinated action of hepatocytes, hepatic stellate cells (HSCs), and endothelial cells. However, their in vivo properties are not fully understood. We report here that the chemokine CXCL10 regulates hepatic tissue remodeling in a carbon tetrachloride (CCl(4))-induced acute liver injury in mice. The production of CXCL10 was enhanced by hepatocytes after CCl(4) exposure. Neutralization of CXCL10 protected mice from acute liver dysfunction and diminished hepatocellular loss. The hepatoprotective effect was associated with increased numbers of 5'-bromo-2' deoxyuridine (BrdU)+ hepatocytes from day 1 and with accumulation of HSCs and endothelial cells within the injured zones from day 3. In vitro, recombinant CXCL10 directly inhibited the proliferation of hepatocytic cells, establishing a novel role of CXCL10 in modulating hepatocyte proliferation, in addition to a previously reported angiostatic role. In summary, neutralization of CXCL10 initially stimulates hepatocyte proliferation and, subsequently, HSC migration and angiogenesis to facilitate remodeling of hepatic cords. Thus, CXCL10 can be a novel therapeutic target for acute hepatocellular damage by regulating liver tissue remodeling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18085377     DOI: 10.1007/s00795-007-0371-x

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  31 in total

Review 1.  Regulation of Th1 and Th2 immune responses by chemokines.

Authors:  H Yoneyama; S Kawasaki; K Matsushima
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes.

Authors:  A Bonacchi; P Romagnani; R G Romanelli; E Efsen; F Annunziato; L Lasagni; M Francalanci; M Serio; G Laffi; M Pinzani; P Gentilini; F Marra
Journal:  J Biol Chem       Date:  2001-01-02       Impact factor: 5.157

3.  Clinical significance of elevated serum interferon- inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels.

Authors:  Y Itoh; A Morita; K Nishioji; S Narumi; T Toyama; Y Daimon; H Nakamura; T Kirishima; T Okanoue
Journal:  J Viral Hepat       Date:  2001-09       Impact factor: 3.728

4.  Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury.

Authors:  Janette Glaser; Rafael Gonzalez; Victoria M Perreau; Carl W Cotman; Hans S Keirstead
Journal:  J Neurosci Res       Date:  2004-09-01       Impact factor: 4.164

5.  Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice.

Authors:  H Yoneyama; A Harada; T Imai; M Baba; O Yoshie; Y Zhang; H Higashi; M Murai; H Asakura; K Matsushima
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

6.  Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival.

Authors:  Shunya Sasaki; Hiroyuki Yoneyama; Kenji Suzuki; Hidehisa Suriki; Tsuneo Aiba; Shiro Watanabe; Yusuke Kawauchi; Hiroshi Kawachi; Fujio Shimizu; Kouji Matsushima; Hitoshi Asakura; Shosaku Narumi
Journal:  Eur J Immunol       Date:  2002-11       Impact factor: 5.532

7.  Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice.

Authors:  Koji Nakamura; Hidenori Nonaka; Hiroki Saito; Minoru Tanaka; Atsushi Miyajima
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

8.  Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis.

Authors:  Shosaku Narumi; Toshikatu Kaburaki; Hiroyuki Yoneyama; Hiroyuki Iwamura; Yuko Kobayashi; Kouji Matsushima
Journal:  Eur J Immunol       Date:  2002-06       Impact factor: 5.532

9.  Foxf1 +/- mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury.

Authors:  Vladimir V Kalinichenko; Dibyendu Bhattacharyya; Yan Zhou; Galina A Gusarova; Wooram Kim; Brian Shin; Robert H Costa
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

10.  An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.

Authors:  Laura Lasagni; Michela Francalanci; Francesco Annunziato; Elena Lazzeri; Stefano Giannini; Lorenzo Cosmi; Costanza Sagrinati; Benedetta Mazzinghi; Claudio Orlando; Enrico Maggi; Fabio Marra; Sergio Romagnani; Mario Serio; Paola Romagnani
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  10 in total

1.  Genomic indicators in the blood predict drug-induced liver injury.

Authors:  J Huang; W Shi; J Zhang; J W Chou; R S Paules; K Gerrish; J Li; J Luo; R D Wolfinger; W Bao; T-M Chu; Y Nikolsky; T Nikolskaya; D Dosymbekov; M O Tsyganova; L Shi; X Fan; J C Corton; M Chen; Y Cheng; W Tong; H Fang; P R Bushel
Journal:  Pharmacogenomics J       Date:  2010-08       Impact factor: 3.550

2.  Hepatoprotective effects of baicalein against CCl₄-induced acute liver injury in mice.

Authors:  Hai-Li Huang; Ya-Jing Wang; Qing-Yu Zhang; Bin Liu; Fang-Yuan Wang; Jing-Jing Li; Run-Zhi Zhu
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

3.  CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.

Authors:  Edith Hintermann; Monika Bayer; Josef M Pfeilschifter; Andrew D Luster; Urs Christen
Journal:  J Autoimmun       Date:  2010-10-06       Impact factor: 7.094

4.  Tissue-Specific Regulation of p38α-Mediated Inflammation in Con A-Induced Acute Liver Damage.

Authors:  Young Jun Kang; Bo-Ram Bang; Motoyuki Otsuka; Kinya Otsu
Journal:  J Immunol       Date:  2015-04-17       Impact factor: 5.422

5.  Oroxylin A accelerates liver regeneration in CCl₄-induced acute liver injury mice.

Authors:  Runzhi Zhu; Guofang Zeng; Yinqin Chen; Qingyu Zhang; Bin Liu; Jie Liu; Hege Chen; Mingyi Li
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

6.  Kupffer cells promote T-cell hepatitis by producing CXCL10 and limiting liver sinusoidal endothelial cell permeability.

Authors:  Shen Dai; Fengming Liu; Zhongnan Qin; Jinyan Zhang; Jiayi Chen; Wen-Xing Ding; Dechun Feng; Yong Ji; Xuebin Qin
Journal:  Theranostics       Date:  2020-06-01       Impact factor: 11.556

7.  The role of interferon-γ inducible protein-10 in a mouse model of acute liver injury post induced pluripotent stem cells transplantation.

Authors:  Che-Chang Chan; Ling-Yi Cheng; Jean Lu; Yi-Hsiang Huang; Shih-Hwa Chiou; Ping-Hsing Tsai; Teh-Ia Huo; Han-Chieh Lin; Fa-Yauh Lee
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

8.  Three-dimensional imaging of hepatic sinusoids in mice using synchrotron radiation micro-computed tomography.

Authors:  Yae Jin Yoon; Soeun Chang; Oh Youn Kim; Bo-Kyeong Kang; Jaesung Park; Jae-Hong Lim; Jung Yun Huang; Yoon-Keun Kim; Jae Ho Byun; Yong Song Gho
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

9.  Proper heat shock pretreatment reduces acute liver injury induced by carbon tetrachloride and accelerates liver repair in mice.

Authors:  San-Qiang Li; Dong-Mei Wang; You-Ju Shu; Xue-Dong Wan; Zheng-Shun Xu; En-Zhong Li
Journal:  J Toxicol Pathol       Date:  2013-12-26       Impact factor: 1.628

10.  NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid.

Authors:  Kathy L de Graaf; Geneviève Lapeyre; Florence Guilhot; Walter Ferlin; Stuart M Curbishley; Marco Carbone; Paul Richardson; Sulleman Moreea; C Anne McCune; Stephen D Ryder; Roger W Chapman; Annarosa Floreani; David E Jones; Cristina de Min; David H Adams; Pietro Invernizzi
Journal:  Hepatol Commun       Date:  2018-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.